Wenfeng Zhang

Dr. Wenfeng Zhang


Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 February 2024 in Microbiological Research
Verified
Journal Article
Closed access
ZCZhou Chuandong
Zhou Chuandong
JHJicong Hu
Jicong Hu
JLJiawen Li
Jiawen Li
YWYuting Wu
Yuting Wu
CWChan Wu
Chan Wu
HSHongwei Shao
Hongwei Shao

1 September 2020 in Molecular Therapy - Methods & Clinical Development
Verified
Journal Article
Open access
HWHui Wang
Hui Wang
HLHua Lu
Hua Lu
YLYing-Shou Lei
Ying-Shou Lei
CGChen-Yu Gong
Chen-Yu Gong
ZCZhao Chen
Zhao Chen
WZWenfeng Zhang
Wenfeng Zhang
Development of the CRISPR-Cas9 gene-editing system has given rise to a new era of gene editing with wide applications in biology, medicine, agriculture, and other fields. However, the overexpression of Cas9 nuclease causes off-target effects and may trigger an immune response in vivo. Therefore, we constructed a self-restricting CRISPR-Cas9 system, where the target gene sequence corresponding to the guide RNA (gRNA) is inserted on either end of the Cas9 promoter. When double-strand breaks (DSBs) are induced in the target gene sequence, the Cas9 promoter is cut off and transcription ceases. With this system, expression of Cas9 protein at 60 h after transfection is only 10% that of the wild-type system, with about 70% promoter deletion efficiency. The target site editing efficiency and homologous recombination efficiency of the self-restricting system remain at about 50% and 30%, respectively, while the frequency of off-target indel formation decreased by 76.7%. Further, the number of indel types was also reduced from 13 to 2. Because this system does not include additional gRNA sequences, the possibility of introducing new off-target mutations is decreased. Importantly, this system is composed of a single plasmid, which could potentially be easily introduced in vivo using a viral vector or nanoparticles.

9 February 2024 in Molecular Therapy
Verified
Journal Article
Open access
WZWenfeng Zhang
Wenfeng Zhang
HWHaozheng Wang
Haozheng Wang
ZLZhongtao Luo
Zhongtao Luo
YJYingzhen Jian
Yingzhen Jian
CGChenyu Gong
Chenyu Gong
HSHongwei Shao
Hongwei Shao
CRISPR/Cas9 is the most commonly used genome editing tool in eukaryotic cells. To modulate Cas9 entry into the nucleus to enable control of genome editing, we constructed a light-controlled CRISPR/Cas9 system to control exposure of the Cas9 protein NLS. Although blue light irradiation was found to effectively control the entry of Cas9 protein into the nucleus with confocal microscopy observation, effective gene editing occurred in controls with next-generation sequencing analysis. To further clarify this phenomenon, a CRISPR/Cas9 editing system without the NLS and a CRISPR/Cas9 editing system containing an NES were also constructed. Interestingly, both Cas9 proteins could achieve effective editing of target sites with significantly reduced off-target effects. Thus, we speculated that other factors might mediate Cas9 entry into the nucleus. However, NLS-free Cas9 was found to produce effective target gene editing even following inhibition of cell mitosis to prevent nuclear import caused by nuclear membrane disassembly. Furthermore, multiple nucleus-localized proteins were found to interact with Cas9, which could mediate the hitchhiking of NLS-free Cas9 into the nucleus. These findings will inform future attempts to construct controllable gene editing systems, as well as provide new insights into the evolution of the nucleus and of compatible protein functions.

1 December 2023 in Human Gene Therapy
Verified
Journal Article
Closed access
JLJiawen Li
Jiawen Li
CTChuxi Tang
Chuxi Tang
GLGuozheng Liang
Guozheng Liang
HTHuiqun Tian
Huiqun Tian
GLGuanxi Lai
Guanxi Lai
HSHongwei Shao
Hongwei Shao
The clustered regularly interspaced short palindromic repeat (CRISPR)- CRISPR-associated (Cas) system is a powerful genomic DNA editing tool. The increased applications of gene editing tools, including the CRISPR-Cas system, have contributed to recent advances in biological fields, such as genetic disease therapy, disease-associated gene screening and detection, and cancer therapy. However, the major limiting factor for the wide application of gene editing tools is gene editing efficiency. This review summarizes the recent advances in factors affecting the gene editing efficiency of the CRISPR-Cas9 system and the CRISPR-Cas9 system optimization strategies. The homology-directed repair efficiency-related signal pathways and the form and delivery method of the CRISPR-Cas9 system are the major factors that influence the repair efficiency of gene editing tools. Based on these influencing factors, several strategies have been developed to improve the repair efficiency of gene editing tools. This review provided novel insights for improving the repair efficiency of the CRISPR-Cas9 gene editing system, which may enable the development and improvement of gene editing tools.

2 September 2020 in Indian Journal of Microbiology
Verified
Journal Article
Closed access
PDF file
QLQiang Li
Qiang Li
HWHui Wang
Hui Wang
CGChen-Yu Gong
Chen-Yu Gong
ZCZhao Chen
Zhao Chen
JYJia-Xing Yang
Jia-Xing Yang
WZWenfeng Zhang
Wenfeng Zhang

1 February 2023 in Human Gene Therapy
Verified
Journal Article
Closed access
HWHaozheng Wang
Haozheng Wang
YWYangmin Wang
Yangmin Wang
ZLZhongtao Luo
Zhongtao Luo
XLXinjian Lin
Xinjian Lin
MLMeilin Liu
Meilin Liu
WZWenfeng Zhang
Wenfeng Zhang
The CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats)-based genome editing system exhibits marked potential for both gene editing and gene therapy, and its continuous improvement contributes to its great clinical potential. However, the largest hindrance to its application in clinical practice is the presence of off-target effects (OTEs). Thus, in addition to continuous optimization of the CRISPR system to reduce and eventually eliminate OTEs, further development of unbiased genome-wide detection of OTEs is key for its successful clinical application. This paper summarizes detection strategies for off-target effects of different CRISPR systems, in order to provide detailed guidance for the detection of OTEs in CRISPR-based genome editing.